Search

Sila Bal, MD, MPH, a PGY-4 ophthalmology resident, is the 2021 recipient of the Best Clinical Trainee Research Award in Cornea and Refractive Surgery. Presented by the Harvard Ophthalmology Cornea Center of Excellence, this award honors the resident or clinical fellow who has conducted the best...

An internationally recognized expert in Age-related Macular Degeneration (AMD) and renowned vitreoretinal surgeon, Demetrios Vavvas, MD, PhD, was promoted to Professor of Ophthalmology at Harvard Medical School (HMS), effective June 1, 2021. He is the first incumbent of the Monte J. Wallace...

Congratulations to the following Department of Ophthalmology faculty on their recent Harvard Medical School promotions and appointments. Nahyoung Grace Lee, MD Associate Professor of Ophthalmology at Harvard Medical School/Mass Eye and Ear (effective May 1, 2021) Michael Lin, MD Assistant Professor...

BOSTON -- The Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology today announced the availability of a comprehensive genetic diagnostic test for inherited eye diseases. The Genetic Eye Disease (GEDi) test uses two DNA sequencing technologies to simultaneously analyze...

Limbal stem cells -- identified with a new marker -- could reverse a leading cause of blindness BOSTON (July 2, 2014) -- Boston researchers have identified a way to enhance regrowth of human corneal tissue to restore vision, using a molecule known as ABCB5 that acts as a marker for hard-to-find...

Charles Osgood interviews Joseph Ciolino, MD, about treating glaucoma with a drug-eluting contact lens. Click here to listen (and for transcript). Related: Press release from Mass. Eye and Ear

The graduation ceremony for the HMS Ophthalmology Class of 2016 trainees was held on June 16, 2016, at 4:00 pm in the Meltzer Auditorium at Mass. Eye and Ear. Thirty-five trainees were recognized, including eight HMS Ophthalmology Residents, the Chief Resident, and one Optometry Resident, as well as...

It was an impressive show Mass. Eye and Ear and Schepens Eye Research Institute of Mass. Eye and Ear trainees, who placed first, second, and third in the New England Ophthalmological Society (NEOS) annual poster contest held earlier this month. Congratulations to: First place: “Exosome-associated...

New findings may stimulate the development of targeted therapies for proptosis in patients with acute thyroid eye disease Boston, Mass. — Researchers from Mass. Eye and Ear - including Schepens Eye Research Institute - and Boston Children's Hospital have identified new underlying mechanisms of...

The strategic licensing agreement between Lonza and Massachusetts Eye and Ear® underscores Lonza’s position as a leading AAV manufacturing service provider and offers customers unprecedented technology and services to commercialize next generation gene therapies. The Anc-AAV vector platform has the...